Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Thoracic 1Genitourinary 1

Conditions

Sarcoma 2Oligodendroglioma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Kidney Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Dendritic Cell Sarcoma, Interdigitating 1Chordoma 1Carcinoma, Non-Small-Cell Lung 1Astrocytoma 1

Interventions

Doxorubicin 142Ifosfamide 85Radiotherapy 82Cyclophosphamide 72Gemcitabine 63Filgrastim 54pembrolizumab 43pazopanib 40Etoposide 39Docetaxel 39Vincristine 37Trabectedin 37Cisplatin 35Nivolumab 32Magnetic Resonance Spectroscopy 26Irinotecan 26Carboplatin 25Temozolomide 23Surgical Procedures, Operative 23Radiation 22Ipilimumab 22Bevacizumab 20Blood Specimen Collection 19Granulocyte Colony-Stimulating Factor 18Biopsy 18eribulin 17Sirolimus 17Mesna 17Melphalan 17Dactinomycin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma × Panobinostat × Sarcoma × Clear all
NCT01005797 2017-03-03

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Medical University of South Carolina

Phase 1 Completed
38 enrolled
GenitourinarySarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Sarcoma

NCT01136499 2013-03-06

ESTIM-LBH

Centre Leon Berard

Phase 2 Completed
53 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡